Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies

por D’Angelo, Alberto, Sobhani, Navid, Chapman, Robert, Bagby, Stefan, Bortoletti, Carlotta, Traversini, Mirko, Ferrari, Katia, Voltolini, Luca, Darlow, Jacob, Roviello, Giandomenico
Publicado 2020

Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2− Breast Cancer Based on a Window of Opportunity Study

por D’Angelo, Alberto, Giudici, Fabiola, Chapman, Robert, Darlow, Jacob, Kilili, Huseyin, Sobhani, Navid, Cinelli, Mattia, Cappelletti, Maria Rosa, Strina, Carla, Milani, Manuela, Generali, Daniele
Publicado 2022